[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2025 World Pulmonary Drugs Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 124 pages | ID: 2BE81ADB6A1CEN
HeyReport

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Pulmonary Drugs , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Pulmonary Drugs market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc)
  • South America (Brazil, Argentina etc)
  • Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
  • Inhaled Corticosteroids (ICS)
  • Long-Acting Beta2-Agonists (LABA)
  • Antihistamine
  • Vasodilators
  • Short-Acting Beta2-Agonists (SABA)
  • Anticholinergics
  • Combination Drugs
  • MAbs
  • Enzymes
  • Antibiotics & Antileukotrienes
By End-User / Application
  • Asthma & COPD
  • Allergic Rhinitis
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis
By Company
  • AstraZeneca plc
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • Actelion Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • Sunovion Pharmaceuticals
1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.NOVOZYMES ASTRAZENECA PLC

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Bayer AG
12.3 Teva Pharmaceutical Industries Ltd
12.4 Actelion Pharmaceuticals, Inc.
12.5 Boehringer Ingelheim GmbH
12.6 F. Hoffmann-La Roche Ltd.
12.7 Merck & Co., Inc.
12.8 Novartis AG
12.9 GlaxoSmithKline plc
12.10 Sunovion Pharmaceuticals

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Pulmonary Drugs Market and Growth by Type
Table Global Pulmonary Drugs Market and Growth by End-Use / Application
Table Global Pulmonary Drugs Revenue (Million USD) by Vendors (2017-2019)
Table Global Pulmonary Drugs Revenue Share by Vendors (2017-2019)
Table Global Pulmonary Drugs Market Volume (Volume) by Vendors (2017-2019)
Table Global Pulmonary Drugs Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table Global Pulmonary Drugs Market Share by Type (2017-2019)
Table Global Pulmonary Drugs Market Volume (Volume) by Type (2017-2019)
Table Global Pulmonary Drugs Market Volume Share by Type (2017-2019)
Table Global Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Global Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table Global Pulmonary Drugs Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Pulmonary Drugs Market Volume Share by End-Use / Application (2017-2019)
Table Global Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table Global Pulmonary Drugs Market Share by Regions (2017-2019)
Table Global Pulmonary Drugs Market Volume (Volume) by Regions (2017-2019)
Table Global Pulmonary Drugs Market Volume Share by Regions (2017-2019)
Table North America Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table North America Pulmonary Drugs Market Share by Type (2017-2019)
Table North America Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table North America Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table North America Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table North America Pulmonary Drugs Market Share by Regions (2017-2019)
Table Europe Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table Europe Pulmonary Drugs Market Share by Type (2017-2019)
Table Europe Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table Europe Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table Europe Pulmonary Drugs Market Share by Regions (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market Share by Type (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Pulmonary Drugs Market Share by Regions (2017-2019)
Table South America Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table South America Pulmonary Drugs Market Share by Type (2017-2019)
Table South America Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table South America Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table South America Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market Share by Regions (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market Share by Type (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Pulmonary Drugs Market Share by Regions (2017-2019)
Table Global Pulmonary Drugs Market (Million USD) Forecast by Regions (2020-2025)
Table Global Pulmonary Drugs Market Share Forecast by Regions (2020-2025)
Table Global Pulmonary Drugs Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Pulmonary Drugs Market Volume Share Forecast by Regions (2020-2025)
Table Global Pulmonary Drugs Market (Million USD) Forecast by Type (2020-2025)
Table Global Pulmonary DrugsMarket Share by Forecast Type (2020-2025)
Table Global Pulmonary Drugs Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Pulmonary Drugs Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca plc
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Actelion Pharmaceuticals, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline plc
Table Sales Revenue, Volume, Price, Cost and Margin of Sunovion Pharmaceuticals

LIST OF FIGURES

Figure Global Pulmonary Drugs Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Pulmonary Drugs Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Pulmonary Drugs Market Volume (Volume) and Growth Forecast (2020-2025)


More Publications